Publication: Coronary artery events in Thai patients with psoriasis using Framingham and Ramathibodi Electricity Generating Authority of Thailand risk scores
20
Issued Date
2015-08-01
Resource Type
ISSN
1875855X
19057415
19057415
Other identifier(s)
2-s2.0-84983212581
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Biomedicine. Vol.9, No.4 (2015), 495-500
Suggested Citation
Sakunee Khankham, Leena Chularojanamontri, Chanisada Wongpraparut, Narumol Silpa-Archa, Nuttaporn Janyong, Prin Vathesatogkit Coronary artery events in Thai patients with psoriasis using Framingham and Ramathibodi Electricity Generating Authority of Thailand risk scores. Asian Biomedicine. Vol.9, No.4 (2015), 495-500. doi:10.5372/1905-7415.0904.419 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/35417
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Coronary artery events in Thai patients with psoriasis using Framingham and Ramathibodi Electricity Generating Authority of Thailand risk scores
Other Contributor(s)
Abstract
Background: Psoriasis is an independent risk factor for cardiovascular disease. Several tools such as Framingham score (FRS) and Ramathibodi-Electricity Generating Authority of Thailand (RAMA-EGAT) score have been developed to predict the 10-year risk of coronary artery disease (CAD) and death. However, there are only few studies determine CAD risk using FRS and RAMA-EGAT score in Asian patients with psoriasis. Objectives: To investigate the risk of CAD events using the FRS and RAMA-EGAT score in Thai patients with psoriasis. Methods: Predictive factors that associated with intermediate and high risk (≥10%) of CAD events within 10-year were determined. Variables, including age, sex, blood pressure, cholesterol, high-density lipoprotein, diabetes mellitus, waist circumference, smoking, and alcohol intake were used to calculate scores. Results: Of 145 patients with psoriasis and a mean age of 48.1 ± 14.1 years, 72 patients were men. Using FRS and RAMA-EGAT, 25% and 13% of the patients, respectively had a ≥10% risk of developing CAD events. A higher risk of CAD was predicted when severe psoriasis was considered. The duration of disease and treatment were associated with an increased risk of CAD using the FRS and RAMA-EGAT score by multivariate analysis. Conclusions: A substantial portion of our patients had a CAD risk ≥10%, with significant relationship with duration of disease and treatment. Early screening of CAD and appropriate treatments of psoriasis may be helpful for preventing CAD in patients with psoriasis.